Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production

Life Sci. 1997;60(3):215-20. doi: 10.1016/s0024-3205(96)00618-2.

Abstract

Injection of zymosan-activated plasma into the rat paw induced oedema formation. Subplantar injection of the non isoform- selective inhibitors of nitric oxide (NO) synthase, N(G)-nitro-L-Arginine methyl ester and N(G)-methyl-L-Arginine, and of a scavenger of NO, haemoglobin, inhibited the early phase of oedema development. Inhibition of cyclooxygenase activity by indomethacin reduced the late increase in paw volume after the injection of zymosan-activated plasma. Methylene blue, an inhibitor of the soluble guanylate cyclase, had no effect. Our results suggest that in paw oedema induced by zymosan-activated plasma, the inflammatory response is dependent on NO (for the early phase) and prostaglandins (for the late phase). The effect of NO is likely to be mediated by a pathway which does not involve cyclic GMP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / pharmacology
  • Cyclooxygenase Inhibitors / pharmacology
  • Dose-Response Relationship, Drug
  • Edema / chemically induced*
  • Edema / metabolism
  • Enzyme Inhibitors / pharmacology
  • Foot Diseases / chemically induced
  • Foot Diseases / metabolism
  • Hemoglobins / pharmacology
  • Indomethacin / pharmacology
  • Inflammation / chemically induced
  • Inflammation / metabolism*
  • Male
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / biosynthesis*
  • Prostaglandins / biosynthesis*
  • Rats
  • Zymosan / blood
  • Zymosan / toxicity*
  • omega-N-Methylarginine / pharmacology

Substances

  • Cyclooxygenase Inhibitors
  • Enzyme Inhibitors
  • Hemoglobins
  • Prostaglandins
  • omega-N-Methylarginine
  • Nitric Oxide
  • Zymosan
  • Arginine
  • NG-Nitroarginine Methyl Ester
  • Indomethacin